245.6001.52% ( -3.800 )
Delay Trading: Nov 17, 10:14:00Valuation
Current ValuationThe current P/E ratio is 53.55, below the reasonable range, cheaper than 98.47% of the time in the past 1 years, and the industry ranks 20/78, the industry Median -4.86.
53.55xP/E
HK$249.40Stock price
HK$4.66Earnings per share
53.55xP/E
Stock priceHK$249.40Earnings per shareHK$4.66
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 74.25x
- Typical range
- 64.67x–561.10x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
0152304456608
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
| Name/Symbol | |||
|---|---|---|---|
06160HKBEONE MEDICINES | 53.55x | 268.27% | HK$384.65B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
